Antibody Therapy Lengthens Survival of Metastatic Melanoma Patients in Large Clinical Trial, Dana-Farber Cancer Institute Study
ScienceDaily (June 5, 2010) — A therapy that multiplies the effect of a natural disease-fighting antibody has extended the lives of patients with metastatic melanoma in a large, international clinical trial.